Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Vaccines”

2,088 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,088 results

Early research (Phase 1)Study completedNCT02544880
What this trial is testing

PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck Cancer
Donald T. Weed, MD, FACS 16
Early research (Phase 1)Study completedNCT01634503
What this trial is testing

Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3

Who this might be right for
Cervical Intraepithelial Neoplasia 3
Genexine, Inc. 9
Testing effectiveness (Phase 2)Ended earlyNCT00006113
What this trial is testing

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University of Southern California 25
Early research (Phase 1)UnknownNCT01266720
What this trial is testing

HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)

Who this might be right for
Pancreatic Cancer
Fukushima Medical University 6
Early research (Phase 1)Ended earlyNCT01403285
What this trial is testing

Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma

Who this might be right for
Glioblastoma
Immatics Biotechnologies GmbH 6
Testing effectiveness (Phase 2)Temporarily pausedNCT05672355
What this trial is testing

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaCOVID-19 Infection
City of Hope Medical Center 80
Testing effectiveness (Phase 2)Study completedNCT06614140
What this trial is testing

Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors

Who this might be right for
CancerSolid Tumor, Adult
Seqker Biosciences, Inc. 8
Early research (Phase 1)Study completedNCT00199849
What this trial is testing

NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine

Who this might be right for
Prostate CancerBladder CancerNon-small Cell Lung Cancer+2 more
Ludwig Institute for Cancer Research 18
Large-scale testing (Phase 3)WithdrawnNCT02100618
What this trial is testing

Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline
Not applicableStudy completedNCT00574886
What this trial is testing

Idiotype Vaccine After Chemotherapy & Stem Cell Transplantation in Lymphoma With Failed Induction Chemotherapy

Who this might be right for
Lymphoma
University of Nebraska 2
Testing effectiveness (Phase 2)Study completedNCT01696877
What this trial is testing

A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer

Who this might be right for
Prostate Cancer Adenocarcinoma in Situ
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 29
Testing effectiveness (Phase 2)Looking for participantsNCT06157151
What this trial is testing

PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical CancerHPV-Related CarcinomaHPV-Related Malignancy+2 more
Precigen, Inc 24
Large-scale testing (Phase 3)Study completedNCT03493542
What this trial is testing

Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)

Who this might be right for
Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in Situ
Merck Sharp & Dohme LLC 766
Testing effectiveness (Phase 2)UnknownNCT05273541
What this trial is testing

Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With Cancer

Who this might be right for
Patients With CancerVaccine ReactionCOVID-19
Beijing 302 Hospital 100
Early research (Phase 1)Study completedNCT04084951
What this trial is testing

Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Adult Solid Tumor
SQZ Biotechnologies 30
Early research (Phase 1)Study completedNCT00004929
What this trial is testing

Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 15
Testing effectiveness (Phase 2)UnknownNCT01924156
What this trial is testing

DC Vaccine Combined With CIK Cells in Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Affiliated Hospital to Academy of Military Medical Sciences 30
Early research (Phase 1)Study completedNCT00078494
What this trial is testing

Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Neoplasms
National Institutes of Health Clinical Center (CC) 99
Not applicableWithdrawnNCT04775056
What this trial is testing

Evaluate Vaccines Against COVID-19 in the Real World

Who this might be right for
Chronic Liver DiseaseHepatic Carcinoma
Humanity & Health Medical Group Limited
Large-scale testing (Phase 3)Study completedNCT01047345
What this trial is testing

V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)

Who this might be right for
Cervical CancersVulvar CancersVaginal Cancers+1 more
Merck Sharp & Dohme LLC 924
Load More Results